Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Learn when mutual funds can be preferable to index funds, considering objectives, risk tolerance, and horizon. Make informed allocation decisions.
25,127 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
A federal watchdog uncovered millions in preopening costs at a Texas detention facility, raising questions about budg...
SoFi Technologies has dropped about 42% over the last six months, trading near $16 as market conditions tighten. Anal...
AI momentum has pushed markets higher, but one stock stands out as a potential tech stock with eyes. This piece break...
As EV demand grows and policy shifts unfold, investors are sizing up 2026. This guide breaks down the chances of a re...
Rivian shares traded near $14.90 as macro headwinds pressure EV names, while a still-growing VW software venture keep...
A landmark housing bill cleared Congress this week, promising to ease rents and expand homebuilding. President Trump ...
A durable industrial leader with long-term contracts stands out as markets tilt toward defensives. Here’s why this in...
As Solana enters a two-decade horizon, this article examines how AI-driven finance and real-world asset tokenization ...
Two semiconductor giants vie for AI-led growth. This article breaks down how revenue growth rates and company scale s...
A bold growth push could redefine Energy Transfer's cash flow and risk. This year’s capex plan signals a major shift ...
Investors are asking whether the AI infrastructure boom is a bubble. This article dives into real-world data, global ...